MicroRNA-384 Inhibits the Progression of Papillary Thyroid Cancer by Targeting PRKACB

Table 1

Clinicopathologic characteristics of miR-384 expression in PTC patients.

Clinicopathological variables	miR-384 expression		value
	Low	High
Age (years)
<45	6	12	0.089
≥45	23	17
Gender
Male	7	13	0.097
Female	22	16
Tumor size (cm)
<2	17	27	0.002
≥2	12	2
N classification			0.000
Yes	17	2
No	12	27